Dulaglutide
Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes
Company n/r · Phase 3 · Completed · Enrollment 150
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Dulaglutide
Company n/r · Phase 3 · Completed · Enrollment 150
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.